Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy | Image Analysis

 

 

View Channel

IT Solutions and Laboratory Automation

 

 

View Channel

 

Conferences | Events

Performing Gas Liquid Chemistries in a Controlled Manner

Using a Uniqsis FlowSyn™ flow reactor system - Sygnature Discovery (Nottingham, UK), a leading provider of integrated drug discovery services to the pharmaceutical industry, has reported results demonstrating how the system allows them to perform traditionally hazardous chemistries in a controlled manner

Uniqsis FlowSyn™ flow reactor system For example, using the proprietary FlowSyn technology with a Uniqsis GAM IIgas-liquid reactor, laboratory scientists at Sygnature Discovery, in conjunction with Uniqsis, have developed high pressure reaction protocols that have enabled them to reproducibly perform carbonylation chemistries under continuous flow through conditions.

Dr Daniel Hamza, a senior research chemist at Sygnature Discovery commented "The option to use a gas addition module has opened up a multitude of gas-liquid reaction chemistries that we can perform using our FlowSy nsystem". He added "The FlowSyn is a straightforward and robust piece of kit to operate. The ability to add on new reactors to the existing set-up is of particular benefit since the latest technology can be easily incorporated into our synthetic plans". In conclusion Dr Hamza said "Flow chemistry offers many advantages over traditional batch processing methods notably better reproducibility and scalability as well as enhanced safety, particularly with hazardous reactions such as nitration and carbonylation".

Sygnature Discovery is a leading provider of integrated drug discovery services to the global pharmaceutical industry.  Key areas of expertise include medicinal and synthetic chemistry, computational chemistry and bioscience (in vitro biology and screening).  Sygnature’s team of over 60 industry-experienced chemists and biologists add considerable value to its clients’ drug discovery activities by undertaking complete drug discovery programmes and key elements of the drug discovery process, such as hit finding, hit-to-lead and lead optimisation.  Sygnature’s scientists also provide considerable intellectual input into clients’ projects; thereby generating novel intellectual property.

Uniqsis specialises in the design of meso-scale continuous flow chemistry systems for a wide range of applications in chemical and pharmaceutical research. The company’s aim is to make flow chemistry easily accessible to both novices and experienced users.

For further information on the FlowSyn flow reactor system please visit www.uniqsis.com/paFlowSystem.aspx or contact Uniqsis on +44-845-864-7747 / info@uniqsis.com


 

more news from Uniqsis


 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

Today's Picks

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners